摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

7-piperidinoheptan-1-amine | 123020-01-9

中文名称
——
中文别名
——
英文名称
7-piperidinoheptan-1-amine
英文别名
7-(piperidin-1-yl)heptan-1-amine;1-(7-aminoheptyl)piperidine;1-Piperidineheptanamine;7-piperidin-1-ylheptan-1-amine
7-piperidinoheptan-1-amine化学式
CAS
123020-01-9
化学式
C12H26N2
mdl
——
分子量
198.352
InChiKey
SQHDPISFSHOERW-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    287.3±8.0 °C(Predicted)
  • 密度:
    0.896±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.1
  • 重原子数:
    14
  • 可旋转键数:
    7
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    29.3
  • 氢给体数:
    1
  • 氢受体数:
    2

SDS

SDS:7aa12283afd5eb33b6c971ffc44c02f1
查看

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-氯苯并咪唑7-piperidinoheptan-1-amine异戊醇 为溶剂, 反应 16.0h, 以81%的产率得到N-(7-piperidin-1-ylheptyl)-1H-benzimidazol-2-amine
    参考文献:
    名称:
    Synthesis and biological evaluation of new non-imidazole H3-receptor antagonists of the 2-aminobenzimidazole series
    摘要:
    A novel series of non-imidazole H-3-receptor antagonists was developed, by chemical modification of a potent lead H-3-antagonist composed by an imidazole ring connected through an alkyl spacer to a 2-aminobenzimidazole moiety (e.g., 2-[[3-[4(5)-imidazolyl]propyl]amino]benzimidazole), previously reported by our research group. We investigated whether the removal of the imidazole ring could allow retaining high affinity for the H-3-receptor, thanks to the interactions undertaken by the 2-aminobenzimidazole moiety at the binding site. The imidazole ring of the lead was replaced by a basic piperidine or by a lipophilic p-chlorophenoxy substituent, modulating the spacer length from three to eight methylene groups; moreover, the substituents were moved to the 5(6) position of the benzimidazole nucleus. Within both the 2-alkylaminobenzimidazole series and the 5(6)-alkoxy-2-amino-benzimidazole one, the greatest H-3-receptor affinity was obtained for the piperidine-substituted compounds, while the presence of the p-chlorophenoxy group resulted in a drop in affinity. The optimal chain length was different in the two series. Even if the new compounds did not reach the high receptor affinity shown by the imidazole-containing lead compound, it was possible to get good H-3-antagonist potencies with 2-aminobenzimidazoles having a tertiary amino group at appropriate distance. (c) 2005 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2005.09.063
  • 作为产物:
    描述:
    1,7-二溴庚烷盐酸 、 potassium iodide 作用下, 以 丙酮 为溶剂, 反应 96.0h, 生成 7-piperidinoheptan-1-amine
    参考文献:
    名称:
    与组合抑制组胺N-甲基转移酶活性的新型一类新的非咪唑组胺H(3)受体配体的发展。
    摘要:
    在寻找增强中枢神经系统中组胺能神经传递的新颖方法的同时,开发了一种新型的非咪唑组胺H(3)受体配体,该配体同时对主要组胺代谢酶组胺N-甲基转移酶(HMT)具有较强的抑制活性。新化合物包含氨基喹啉部分,这是HMT抑制活性的重要结构特征,通过不同的间隔基连接到哌啶子基上(对H(3)受体有拮抗作用)。间隔物结构的变化提供了两种不同系列的化合物。一个系列,在基本中心之间只有一个亚烷基间隔基,导致对人组胺H(3)受体具有中等至高亲和力的高效HMT抑制剂。第二系列具有对苯氧丙基间隔基 可以被另一个亚烷基链延长。后一个系列还显示出对HMT的强抑制活性,并且在大多数情况下,H(3)受体的亲和力甚至超过了第一个系列。具有这种双重作用方式的最有效的化合物之一是4-(4-(3-哌啶子基丙氧基)苯氨基)喹啉(34)(hH(3),K(i)= 0.09 nM; HMT,IC(50)= 51 nM)。这类化合物在豚鼠对
    DOI:
    10.1021/jm0110845
点击查看最新优质反应信息

文献信息

  • Alkylenediamine derivatives
    申请人:Nippon Chemiphar Co., Ltd.
    公开号:US05310902A1
    公开(公告)日:1994-05-10
    Novel alkylenediamine derivatives effectively employable glutamate blockers have the formula (I) or (II): ##STR1## wherein each of R.sup.1 and R.sup.6 is an aliphatic hydrocarbon group, an alicyclic hydrocarbon group, an aryl group, or an aralkyl group; each of R.sup.2 and R.sup.7 is an aliphatic hydrocarbon group, an alkoxy group, an aliphatic hydrocarbon group containing an ester bonding, an aliphatic hydrocarbon group containing an ether bonding, or an aryloxy group; each of R.sup.3, R.sup.4, R.sup.5 R.sup.8, R.sup.9 and R.sup.10 is hydrogen, an alkyl group, an alkoxy group, an acyloxy group, an aryl group, an aralkyl group, hydroxyl, a hydroxylalkyl group, halogen, nitrile, nitro, amino, carbamoyl or alkoxycarbonyl; and each of m and n is an integer of 0-3 (m+n does not exceed 3); k is an integer of 1-4; each of p and i is an integer of 2-13; and each of q and j is an integer of 4-7.
    新型烷基二胺衍生物有效地作为谷酸受体阻滞剂,其化学式为(I)或(II):##STR1## 其中,R^1和R^6分别为脂肪烃基、环烷烃基、芳基或芳基烷基;R^2和R^7分别为脂肪烃基、烷氧基、含酯键的脂肪烃基、含醚键的脂肪烃基或芳氧基;R^3、R^4、R^5、R^8、R^9和R^10分别为氢、烷基、烷氧基、酰氧基、芳基、芳基烷基、羟基、羟基烷基、卤素、腈、硝基、基、基甲酰或烷氧羰基;m和n均为0-3的整数(m+n不超过3);k为1-4的整数;p和i均为2-13的整数;q和j均为4-7的整数。
  • MODIFIED BLOCK COPOLYMER, METHOD FOR PRODUCING MODIFIED BLOCK COPOLYMER, AND RESIN COMPOSITION
    申请人:Asahi Kasei Kabushiki Kaisha
    公开号:EP3623398A1
    公开(公告)日:2020-03-18
    A modified block copolymer according to the present invention is a modified block copolymer comprising a polymer block comprising a vinyl aromatic compound as a main constituent (A), a polymer block comprising a conjugate diene compound as a main constituent (B), and an atomic group having NHx (x = 0 to 2) (C). In the modified block copolymer, the polymer block comprising a conjugate diene compound as a main constituent (B) is a hydrogenated product, the atomic group having NHx (x = 0 to 2) (C) is contained in a side chain, and a compound forming the atomic group having NHx (x = 0 to 2) (C) satisfies the following condition: Condition: when the compound forming the atomic group having NHx (x = 0 to 2) (C) is reacted with a maleic anhydride-modified group in a maleic anhydride-modified block copolymer, a MFR value at 230°C under a load of 2.16 kg of the modified block copolymer after the reaction is 0.1 times or more a MFR value at 230°C under a load of 2.16 kg of the maleic anhydride-modified block copolymer before the reaction.
    根据本发明,改性嵌段共聚物是一种改性嵌段共聚物,包括以乙烯基芳香族化合物为主要成分的聚合物嵌段(A)、以共轭二烯化合物为主要成分的聚合物嵌段(B)和具有 NHx(x = 0 至 2)的原子团(C)。在改性嵌段聚合物中,由共轭二烯化合物作为主要成分(B)的聚合物嵌段是氢化产物,具有 NHx(x = 0 至 2)(C)的原子团包含在侧链中,形成具有 NHx(x = 0 至 2)(C)的原子团的化合物满足以下条件: 条件:当形成具有 NHx(x = 0 至 2)(C)的原子团的化合物与马来酸酐改性嵌段共聚物中的马来酸酐改性基团反应时,反应后在 230℃、负载 2.16 千克改性嵌段共聚物时的 MFR 值是反应前在 230℃、负载 2.16 千克马来酸酐改性嵌段共聚物时的 MFR 值的 0.1 倍或以上。
  • Modified block copolymer, method for producing modified block copolymer, and resin composition
    申请人:Asahi Kasei Kabushiki Kaisha
    公开号:US11124593B2
    公开(公告)日:2021-09-21
    A modified block copolymer according to the present invention is a modified block copolymer comprising a polymer block comprising a vinyl aromatic compound as a main constituent (A), a polymer block comprising a conjugate diene compound as a main constituent (B), and an atomic group having NHx (x=0 to 2) (C). In the modified block copolymer, the polymer block comprising a conjugate diene compound as a main constituent (B) is a hydrogenated product, the atomic group having NHx (x=0 to 2) (C) is contained in a side chain, and a compound forming the atomic group having NHx (x=0 to 2) (C).
    根据本发明,改性嵌段共聚物是一种改性嵌段共聚物,包括以乙烯基芳香族化合物为主要成分的聚合物嵌段(A)、以共轭二烯化合物为主要成分的聚合物嵌段(B)和具有 NHx(x=0 至 2)的原子团(C)。在改性嵌段共聚物中,由共轭二烯化合物作为主要成分(B)的聚合物嵌段是氢化产物,具有 NHx(x=0 至 2)(C)的原子团包含在侧链中,以及形成具有 NHx(x=0 至 2)(C)的原子团的化合物。
  • Modified Block Copolymer, Method for Producing Modified Block Copolymer, and Resin Composition
    申请人:Asahi Kasei Kabushiki Kaisha
    公开号:US20200199282A1
    公开(公告)日:2020-06-25
    A modified block copolymer according to the present invention is a modified block copolymer comprising a polymer block comprising a vinyl aromatic compound as a main constituent (A), a polymer block comprising a conjugate diene compound as a main constituent (B), and an atomic group having NHx (x=0 to 2) (C). In the modified block copolymer, the polymer block comprising a conjugate diene compound as a main constituent (B) is a hydrogenated product, the atomic group having NHx (x=0 to 2) (C) is contained in a side chain, and a compound forming the atomic group having NHx (x=0 to 2) (C).
  • US5070196A
    申请人:——
    公开号:US5070196A
    公开(公告)日:1991-12-03
查看更多

同类化合物

(R)-3-甲基哌啶盐酸盐; (R)-2-苄基哌啶-1-羧酸叔丁酯 ((3S,4R)-3-氨基-4-羟基哌啶-1-基)(2-(1-(环丙基甲基)-1H-吲哚-2-基)-7-甲氧基-1-甲基-1H-苯并[d]咪唑-5-基)甲酮盐酸盐 高氯酸哌啶 高托品酮肟 马来酸帕罗西汀 颜料红48:4 顺式3-氟哌啶-4-醇盐酸盐 顺式2,6-二甲基哌啶-4-酮 顺式1-苄基-4-甲基-3-甲氨基-哌啶 顺式-叔丁基4-羟基-3-甲基哌啶-1-羧酸酯 顺式-6-甲基-哌啶-1,3-二甲酸1-叔丁酯 顺式-5-(三氟甲基)哌啶-3-羧酸甲酯盐酸盐 顺式-4-叔丁基-2-甲基哌啶 顺式-4-Boc-氨基哌啶-3-甲酸甲酯 顺式-4-(氮杂环丁烷-1-基)-3-氟哌 顺式-3-顺式-4-氨基哌啶 顺式-3-甲氧基-4-氨基哌啶 顺式-3-BOC-3,7-二氮杂双环[4.2.0]辛烷 顺式-3-(1-吡咯烷基)环丁腈 顺式-3,5-哌啶二羧酸 顺式-3,4-二溴-3-甲基吡咯烷盐酸盐 顺式-2,6-二甲基-4-氧代哌啶-1-羧酸叔丁基酯 顺式-1-叔丁氧羰基-4-甲基氨基-3-羟基哌啶 顺式-1-boc-3,4-二氨基哌啶 顺式-1-(4-叔丁基环己基)-4-苯基-4-哌啶腈 顺式-1,3-二甲基-4-乙炔基-6-苯基-3,4-哌啶二醇 顺-4-(4-氟苯基)-1-(4-异丙基环己基)-4-哌啶羧酸 顺-4-(2-氟苯基)-1-(4-异丙基环己基)-4-哌啶羧酸 顺-3-氨基-4-氟哌啶-1-羧酸叔丁酯 顺-1-苄基-4-甲基哌啶-3-氨基酸甲酯盐酸盐 非莫西汀 雷芬那辛 雷拉地尔 阿维巴坦中间体4 阿格列汀杂质 阿尼利定盐酸盐 CII 阿尼利定 阿塔匹酮 阿哌沙班杂质BMS-591455 阿哌沙班杂质87 阿哌沙班杂质52 阿哌沙班杂质51 阿哌沙班杂质5 阿哌沙班杂质 阿哌沙班杂质 阿哌沙班-d3 阿哌沙班 阻聚剂701 间氨基谷氨酰胺